San Mateo, CA – BigHat Biosciences has announced the appointment of Stefan Weigand as Chief Scientific Officer. About BigHat Biosciences: BigHats mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or wet lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from todays most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids Capital, AME Cloud Ventures, Innovation Endeavors and Gaingels.

For more information visit: https://www.bighatbio.com/

BigHat Biosciences
1900 Alameda de Las Pulgas
San Mateo, CA 94403
Phone: 650-585-3887
LinkedIn: https://www.linkedin.com/company/bighat-biosciences/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved